Additional information
| Trade Name | Kryxana |
|---|---|
| Generic Name | Ribociclib (200mg) |
| Manufacturer | Novartis India Ltd |
| Drug Type | Oncology |
| Indication | Breast Cancer |
| Doasage Form | Tablet |
| Packaging | 21 Tablets |
KRYXANA (Ribociclib)-200 mg
KRYXANA (Ribociclib) is a small molecule cyclin-dependent kinase (CDK) inhibitor. The drug blocks proteins in the cell called cyclin-dependent kinase (CDK) 4 and CDK 6.
Indicated to use with the combination of the aromatase inhibitor to treat HR-Positive and HER2-Negative advanced as well as metastatic breast cancer. Used to treat hormone-related breast cancer in women, when cancer has progressed or has spread to other parts of the body after other treatments.
